Nonalcoholic Fatty Liver Disease
Tóm tắt
Insulin sensitivity (euglycemic clamp, insulin infusion rate: 40 mU · m−2 · min−1) was studied in 30 subjects with biopsy-proven nonalcoholic fatty liver disease (NAFLD), normal glucose tolerance, and a BMI <30 kg/m2. Of those 30 subjects, 9 had pure fatty liver and 21 had evidence of steatohepatitis. In addition, 10 patients with type 2 diabetes under good metabolic control and 10 healthy subjects were studied. Most NAFLD patients had central fat accumulation, increased triglycerides and uric acid, and low HDL cholesterol, irrespective of BMI. Glucose disposal during the clamp was reduced by nearly 50% in NAFLD patients, as well as in patients with normal body weight, to an extent similar to that of the type 2 diabetic patients. Basal free fatty acids were increased, whereas insulin-mediated suppression of lipolysis was less effective (−69% in NAFLD vs. −84% in control subjects; P = 0.003). Postabsorptive hepatic glucose production (HGP), measured by [6,6-2H2]glucose, was normal. In response to insulin infusion, HGP decreased by only 63% of basal in NAFLD vs. 84% in control subjects (P = 0.002). Compared with type 2 diabetic patients, NAFLD patients were characterized by lower basal HGP, but with similarly reduced insulin-mediated suppression of HGP. There was laboratory evidence of iron overload in many NAFLD patients, but clinical, histological, and biochemical data (including insulin sensitivity) were not correlated with iron status. Four subjects were heterozygous for mutation His63Asp of the HFE gene of familiar hemochromatosis. We concluded that NAFLD, in the presence of normoglycemia and normal or moderately increased body weight, is characterized by clinical and laboratory data similar to those found in diabetes and obesity. NAFLD may be considered an additional feature of the metabolic syndrome, with specific hepatic insulin resistance.
Từ khóa
Tài liệu tham khảo
Leevy CM: Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine 41:249–276, 1962
Foster KJ, Griffith AH, Dewbury K, Price CP, Wright R: Liver disease in patients with diabetes mellitus. Postgrad Med J 56:767–772, 1980
Silverman JF, Pories WJ, Caro JF: Liver pathology in diabetes mellitus and morbid obesity: clinical, pathological, and biochemical considerations. Pathol Annu 24:275–302, 1989
Ludwig J, Viaggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc 55:434–438, 1980
Wanless IR, Lentz JS: Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106–1110, 1990
Eriksson S, Eriksson KF, Bondesson L: Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 220:83–88, 1986
Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW: The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74–80, 1990
Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA: Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103–1109, 1994
Itoh S, Yougel T, Kawagoe K: Comparison between non-alcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82:650–654, 1987
Diehl AM, Goodman Z, Ishak KG: Alcoholic disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95:1056–1062, 1988
Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419, 1999
Falchuk KR, Fiske SC, Haggitt RC, Federman R, Trey C: Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 78:535–541, 1980
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia 28:412–419, 1985
Marchesini G, Brizi M, Morselli Labate AM, Bianchi G, Bugianesi G, McCullough AJ, Forlani G, Melchionda N: Association of non-alcoholic fatty liver disease to insulin resistance. Am J Med 107:450–455, 1999
DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194, 1991
Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC: Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 18:353–358, 1999
DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223, 1979
DeFronzo RA, Simonson D, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313–319, 1982
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197, 1997
National Diabetes Data Group: Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 28:1039–1057, 1979
Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, Croce LS, Paoletti S, de Bernard B, Tiribelli C, Dalla Palma L: Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 27:108–113, 1997
Han TS, McNeill G, Seidell JC, Lean ME: Predicting intra-abdominal fat from anthropometric measures: the influence of stature. Int J Obes Relat Metab Disord 21:587–593, 1997
Feder JN, Gnirke A, Thomas W, Tsichihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintler GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK: A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 13:399–408, 1996
Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Diabetes 36:914–924, 1987
Duncan DB: Multiple range test for correlated and heteroscedastic means. Biometrics 13:164–204, 1957
Lee JH, Rhee PL, Lee JK, Lee KT, Kim JJ, Koh KC, Paik SW, Lee WJ, Lim HK, Rhee JC: Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. Korean J Intern Med 13:12–14, 1998
Ferrannini E, Natali A: Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 121:1274–1282, 1991
Björntorp P: Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4:622–627, 1988
Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG: Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513–1517, 1999
DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387–395, 1989
Marchesini G, Pacini G, Bianchi GP, Patrono D, Cobelli C: Glucose disposal, β-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment. Gastroenterology 99:1715–1722, 1990
Wiesenthal SR, Sandhu H, McCall RH, Tchipashvili V, Yoshii H, Polonsky K, Shi ZQ, Lewis GF, Mari A, Giacca A: Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48:766–774, 1999
Goto T, Onuma T, Takebe K, Kral JG: The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 19:841–845, 1995
Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebowitz HE, Kral JG: Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 19:846–850, 1995
George DK, Goldwurm S, McDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311–318, 1998
Morimoto M, Hagbjork AL, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, Albano E, French SW: Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol 10:459–464, 1993
Drenick EJ, Simmons F, Murphy JF: Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 282:829–834, 1970
Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y: A new syndrome of liver iron overload with normal transferrin saturation. Lancet 349:95–97, 1997
Mendler M-H, Turlin B, Moirand R, Jouanolle A-M, Sapey T, Guyader D, Le Gall J-Y, Brissot P, David V, Deugnier Y: Insulin resistance-associated hepatic iron overload. Gastroenterology 117:1155–1163, 1999
Lee KS, Buck M, Houglum K, Chojkier M: Activation of hepatic stellate cells by TGF alpha and collagen type 1 is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461–2468, 1995
Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M: Stimulation of collagen 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 19:1262–1271, 1994
Berson A, De Beco V, Lettéron P, Robin MA, Moreau C, El Kahwaji J, Verthier N, Feldmann G, Fromenty B, Pessayre D: Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114:764–774, 1998
Cotrim HP, Andrade ZA, Parana R, Portugal M, Lyra LG, Freitas LAR: Nonalcoholic steatohepatitis: a toxic liver disease in industrial workers. Liver 19:299–304, 1999
Kern PA, Saghizaheh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111–2119, 1995
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183–1192, 2001